GIMD1
GTPase IMAP family member GIMD1
Also known as: GIMD1_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P0DJR0
- Gene
- GIMD1
- Ensembl
- ENSG00000250298
- Chromosome
- 4
- Canonical length
- 217 aa
- Protein class
- Predicted intracellular proteins
OverviewNCBI Gene
Predicted to enable GTP binding activity. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
217 residues, UniProt reviewed canonical sequence.
>P0DJR0|GIMD1
1 MTDPNKMIIN LALFGMTQSG KSSAGNILLG STDFHSSFAP CSVTTCCSLG RSCHLHSFMR
61 RGGLEVALQV QVLDTPGYPH SRLSKKYVKQ EVKEALAHHF GQGGLHLALL VQRADVPFCG
121 QEVTDPVQMI QELLGHAWMN YTAILFTHAE KIEEAGLTED KYLHEASDTL KTLLNSIQHK
181 YVFQYKKGKS LNEQRMKILE RIMEFIKENC YQVLTFKLocalizationUniProt · AlphaFold · HPA
Whether an antibody against GIMD1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Unknown
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.26
- Highest tissue expression
- 26 nTPM
Expression across tissuesHPA
Tissue
- duodenum: 26 nTPM
- small intestine: 15 nTPM
- gallbladder: 2.8 nTPM
- adipose tissue: 0 nTPM
- adrenal gland: 0 nTPM
- amygdala: 0 nTPM
Single-cell type
- thymocytes: 1.7 nCPM
- schwann cells: 1 nCPM
- endometrial stromal cells: 0.5 nCPM
- enterocytes: 0.5 nCPM
- mast cells: 0.3 nCPM
- mesothelial cells: 0.3 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- amygdala: 0 nTPM
- basal ganglia: 0 nTPM
- cerebellum: 0 nTPM
- cerebral cortex: 0 nTPM
- choroid plexus: 0 nTPM
- hippocampal formation: 0 nTPM
OntologyGO
Molecular functions
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads GIMD1 as an antibody target. Whether an autoantibody or antibody against GIMD1 could matter depends on whether native GIMD1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
GIMD1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label GIMD1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...